This discussion at the Digital Medicine & Medtech Showcase will highlight how AI, and specifically, machine learning, is being used to: identify novel therapeutics; find, characterize and intervene on behalf of patients; integrate social determinants of health and other data to provide new insights into patient care.
At the intersection of technology and medicine, the Digital Medicine & Medtech Showcase will offer more than 70 dedicated company presentations and 500+ attendees exclusively from the digital medicine and medtech sectors.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Insights from investors, biopharma leaders and digital health executives on how to navigate the digital health sector as it transforms every aspect of the pharmaceutical value chain.